100 related articles for article (PubMed ID: 32317300)
1. C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer.
Bodén S; Myte R; Harbs J; Sundkvist A; Zingmark C; Löfgren Burström A; Palmqvist R; Harlid S; Van Guelpen B
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1482-1491. PubMed ID: 32317300
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer.
Myte R; Harlid S; Sundkvist A; Gylling B; Häggström J; Zingmark C; Burström AL; Palmqvist R; Guelpen BV
Sci Rep; 2020 Mar; 10(1):5336. PubMed ID: 32210264
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
5. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
[TBL] [Abstract][Full Text] [Related]
7. Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study.
Wu J; Cai Q; Li H; Cai H; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Carcinogenesis; 2013 Dec; 34(12):2799-803. PubMed ID: 23985781
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of C-reactive protein levels and colorectal adenoma development.
Gunter MJ; Cross AJ; Huang WY; Stanczyk FZ; Purdue M; Xue X; Schoen R; Limburg PJ; Schatzkin A; Sinha R; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):537-44. PubMed ID: 21212059
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
[TBL] [Abstract][Full Text] [Related]
11. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
[TBL] [Abstract][Full Text] [Related]
13. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B
PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk.
Davenport JR; Cai Q; Ness RM; Milne G; Zhao Z; Smalley WE; Zheng W; Shrubsole MJ
Mol Carcinog; 2016 Aug; 55(8):1251-61. PubMed ID: 26333108
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study.
Ito Y; Suzuki K; Tamakoshi K; Wakai K; Kojima M; Ozasa K; Watanabe Y; Kawado M; Hashimoto S; Suzuki S; Tokudome S; Toyoshima H; Hayakawa N; Kato K; Watanabe M; Ohta Y; Maruta M; Tamakoshi A;
J Epidemiol; 2005 Jun; 15 Suppl 2(Suppl II):S185-9. PubMed ID: 16127232
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies.
Kakourou A; Koutsioumpa C; Lopez DS; Hoffman-Bolton J; Bradwin G; Rifai N; Helzlsouer KJ; Platz EA; Tsilidis KK
Cancer Causes Control; 2015 Oct; 26(10):1449-60. PubMed ID: 26220152
[TBL] [Abstract][Full Text] [Related]
17. Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Häggström C; Zingmark C; Löfgren Burström A; Palmqvist R; Van Guelpen B
Int J Cancer; 2019 Jul; 145(2):327-337. PubMed ID: 30613980
[TBL] [Abstract][Full Text] [Related]
18. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
Nielsen HJ; Christensen IJ; Sørensen S; Moesgaard F; Brünner N
Ann Surg Oncol; 2000 Sep; 7(8):617-23. PubMed ID: 11005561
[TBL] [Abstract][Full Text] [Related]
19. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma C-reactive protein level with the prevalence of colorectal adenoma: the Colorectal Adenoma Study in Tokyo.
Kigawa N; Budhathoki S; Yamaji T; Iwasaki M; Inoue M; Tsugane S
Sci Rep; 2017 Jun; 7(1):4456. PubMed ID: 28667300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
